An active treatment of lung adenocarcinoma cancer with brain metastases: icotinib
about
Advanced lung adenocarcinoma with spinal cord metastasis successfully treated with second EGFR-TKI treatment: a case report and literature review.Icotinib combined whole brain radiotherapy for patients with brain metastasis from lung adenocarcinoma harboring epidermal growth factor receptor mutation.[Diffuse and calcified nodular opacities].Tyrosine kinase inhibitors show different anti-brain metastases efficacy in NSCLC: A direct comparative analysis of icotinib, gefitinib, and erlotinib in a nude mouse model.Complete remission through icotinib treatment in Non-small cell lung cancer epidermal growth factor receptor mutation patient with brain metastasis: A case report.
P2860
An active treatment of lung adenocarcinoma cancer with brain metastases: icotinib
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
An active treatment of lung adenocarcinoma cancer with brain metastases: icotinib
@ast
An active treatment of lung adenocarcinoma cancer with brain metastases: icotinib
@en
type
label
An active treatment of lung adenocarcinoma cancer with brain metastases: icotinib
@ast
An active treatment of lung adenocarcinoma cancer with brain metastases: icotinib
@en
prefLabel
An active treatment of lung adenocarcinoma cancer with brain metastases: icotinib
@ast
An active treatment of lung adenocarcinoma cancer with brain metastases: icotinib
@en
P2093
P2860
P356
P1476
An active treatment of lung adenocarcinoma cancer with brain metastases: icotinib
@en
P2093
P2860
P304
P356
10.2147/OTT.S78925
P407
P577
2015-06-08T00:00:00Z